TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000426263 GLUT1 NA NA glioma up-regulated predicted more...
ENST00000426263 GLUT1 NA NA pancreatic cancer up-regulated predicted more...
ENST00000426263 SLC2A1 NA NA breast cancer up-regulated predicted more...
ENST00000426263 SLC2A1 NA Chelator M30 amyotrophic lateral sclerosis up-regulated validated more...
ENST00000426263 SLC2A1 NA Chelator M30 parkinson＇s disease up-regulated validated more...
ENST00000426263 SLC2A1 NA Chelator M30 alzheimer＇s disease up-regulated validated more...
ENST00000426263 GLUT1 DB00620 Triamcinolone diminished fetal growth down-regulated validated more...
ENST00000426263 SLC2A1 DB07810 Phloretin chronic renal failure down-regulated validated more...
ENST00000426263 GLUT1 DB01030 (APRD00687) Topotecan cancer down-regulated validated more...
ENST00000426263 GLUT1 DB07080 TO-901317 hepatocellular carcinoma down-regulated validated more...
ENST00000426263 GLUT1 NA TX-2098 pancreatic cancer down-regulated validated more...
ENST00000426263 GLUT1 DB03285 (EXPT01707) Isoliquiritigenin melanoma down-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3